Sriniketh Sundar, DO
Pain Medicine · Wilmington, DENPI 1366860793
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,744 of the $5,385 with a category attached, or 69.5%. 24 manufacturers reported payments, led by Medtronic at 29.4% of the total. 2025 is the largest year on record at $2,575, 7.6 times the $339 reported in 2019.
Across 113 payments — averaging $47.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Bioventus LLC$1K
- Abbott$748
- Globus Medical$552
- Nevro Corp.$333
- Nalu Medical, Inc.$201
- plus $798 from 18 others
What the payments were for
- Travel & lodging$1,64130%
- Food & beverage$3,74470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 26 | $1,581 |
| Bioventus LLC | 12 | $1,172 |
| Abbott | 13 | $748 |
| Globus Medical | 18 | $552 |
| Nevro Corp. | 9 | $333 |
| Nalu Medical, Inc. | 5 | $201 |
| Boston Scientific | 2 | $131 |
| Pacira Therapeutics, Inc. | 1 | $122 |
| Johnson & Johnson | 3 | $86 |
| Si-bone, Inc. | 2 | $71 |
| Collegium Pharmaceutical, Inc. | 4 | $61 |
| Scilex Pharmaceuticals Inc. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Curonix LLC | 1 | $26 |
| Merck | 1 | $22 |
| Bard Peripheral Vascular, Inc. | 1 | $21 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Stryker | 1 | $17 |
| Smith+Nephew | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,385 in reported general payments places this provider in the 70th percentile of 31 pain medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 21 | $196 |
| Methylprednisolone | 26 | $144 |
| Cyclobenzaprine Hcl | 11 | $82 |
| Tizanidine Hcl | 14 | $60 |
| Tramadol Hcl | 25 | $56 |
| Diazepam | 32 | $51 |
| Meloxicam | 18 | $48 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Wilmington
- Selina XingWilmington$13K
- Alexander MatzWilmington$6K
- Daniel NasrWilmington$6K
- Amir Abdel KaderWilmington$5K
- Chiedozie UwanduWilmington$4K
- Jason RothWilmington$4K
- Manny LaiWilmington$4K
- Chee WooWilmington$3K
- Yasmin ElkhashabWilmington$2K
- Peter WitherellWilmington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.